Redhill Biopharma【RDHL】株式ニュース

名称	銘柄コード	市場	種別
Redhill Biopharma Ltd	RDHL	NASDAQ	Depository Receipt

	前日比	前日比 %	現在値	時刻
	0.0084	1.86%	0.4594	20:31:22

始値	安値	高値	終値	前日終値
				0.451

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/4/24	20:00	PRNUS	RedHill Announces First Patient Enrolled in U.S...
2024/4/08	22:23	PRNUS	RedHill Biopharma Announces Full-Year 2023 Results and..
2024/4/02	20:00	PRNUS	RedHill Biopharma Announces $1.25 Million Registered Direct..
2024/3/11	20:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/11	20:00	PRNUS	RedHill Announces New USPTO Patent Covering Talicia® Through..
2024/3/05	21:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/05	21:00	PRNUS	RedHill's Opaganib Selected for Evaluation by BARDA and NIH..
2024/2/21	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/20	21:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/20	21:00	PRNUS	RedHill's Opaganib Protects Against Radiation-Induced Lung..
2024/2/16	22:54	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/16	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/2/14	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/03	06:10	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/02	00:22	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/27	02:50	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/27	02:46	PRNUS	RedHill Biopharma Announces Closing of $8 Million Registered..
2024/1/26	23:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/26	23:29	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/25	23:09	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/25	23:05	PRNUS	RedHill Biopharma Announces $8 Million Registered Direct..
2024/1/25	20:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/25	20:00	PRNUS	RedHill Announces New USPTO Patent Grant for Talicia® for H...
2023/12/20	22:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/20	22:45	PRNUS	RedHill and U.S. Army Announce Opaganib and RHB-107..
2023/12/12	21:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/12	21:00	PRNUS	RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid..
2023/12/06	21:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/04	21:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/04	21:00	PRNUS	RedHill Announces New, Non-Dilutive External Funding of..
2023/12/02	06:10	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/27	21:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/27	21:00	PRNUS	RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market..
2023/11/17	02:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/14	22:00	PRNUS	RedHill Biopharma Announces the Transfer of its Listing to..
2023/10/27	05:52	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/24	05:06	EDGAR2	Form F-3/A - Registration statement by foreign private..
2023/10/17	05:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/13	21:13	EDGAR2	Form F-3 - Registration statement by foreign private issuers
2023/10/10	22:08	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/03	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/03	20:00	PRNUS	RedHill and U.S. Army Announce Opaganib's Ebola Virus..
2023/9/29	21:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/23	05:17	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/23	05:15	PRNUS	RedHill Biopharma Announces Receipt of Nasdaq Notification..
2023/9/18	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/18	20:00	PRNUS	RedHill Announces FDA sNDA Approval for Talicia®
2023/9/05	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/05	20:00	PRNUS	RedHill Announces New USPTO Notice of Patent Allowance for..
2023/8/17	20:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..

この銘柄に関するニュースをもっと見る »

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

RDHL Redhill Biopharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Redhill Biopharma Ltd (RDHL) ニュース

RDHL Redhill Biopharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手